We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Death Risk of Heart Failure Patients

By HospiMedica staff writers
Posted on 28 Feb 2005
A new practical tool has been developed to predict the high, intermediate, and low risk of death in hospitalized heart failure patients, using two simple blood tests and a single blood pressure measurement.

Investigators used a type of statistical analysis known as CART (classification and regression tree) to analyze a number of clinical variables in order to develop a tool to assess mortality risk in heart failure patients. More...
From an observational evaluation of 39 clinical variables from more than 65,000 hospitalized heart failure patients, they were able to define three clinical characteristics that put patients at greatest risk of mortality. These are high levels of blood urea nitrogen (BUN greater or equal to mg/dl), low systolic blood pressure (SBP > 115 mm HG), and high serum creatinine (Cr greater than or equal to 2.75 mg/dl). The validity of this tool was tested using data from an additional 32,229 hospitalizations.

The overall mortality risk for patients hospitalized with acute heart failure was 4.1%. The new tool determined mortality risk levels starting from low risk at 2.1% up to 21.9% for patients with the highest risk. Clyde W. Yancy, M.D., professor of medicine and cardiology at the University of Texas Southwestern Medical Center (Dallas, USA; www.swmed.edu) was a contributing investigator of the study.

"This new tool is a first for the treatment of acute decompensated heart failure, and offers a simple quick way for clinicians to assess mortality risk upon hospital admission and rapidly decide on a treatment strategy,” noted Gregg C. Fonarow, M.D., professor of medicine in the division of cardiology at the University of California, Los Angeles (USA).

The study was conducted by investigators from the world's largest heart failure registry, known as ADHERE (acute decompensated heart failure), sponsored by Scios, Inc. (San Francisco, CA, USA). The study was published in the February 2, 2005, issue of the Journal of the American Medical Association.


New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gas Analyzer
GE SAM
New
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.